Dedicated to Finding a Cure
The Juvenile Diabetes Research Foundation International is the leader in setting
the agenda for type 1 diabetes research worldwide, and is the world’s largest
charitable funder and advocate of type 1 diabetes research. The mission of JDRF
is to find a cure for diabetes and its complications through the support of
research. Type 1 diabetes is a disease which strikes children and adults
suddenly, but lasts a lifetime. It requires multiple injections of insulin daily
or a continuous infusion of insulin through a pump. Insulin, however, is not a
cure for diabetes, nor does it prevent its eventual and devastating
complications which may include kidney failure, blindness, heart disease,
stroke, amputation, and pregnancy complications.
Building Upon Research Successes
JDRF funding and leadership is associated with most major scientific
breakthroughs in type 1 diabetes research to date. In fact, JDRF funds a major
portion of all type 1 diabetes research worldwide, more than any other charity.
JDRF provided more than $156 million to diabetes research in FY 2008, and is
responsible for more than $1.3 billion in direct funding since it was founded.
Our research review process not only includes leading research scientists from
around the world, but lay reviewers who either have type 1 diabetes or have
family members with type 1 diabetes. This process insures that JDRF funds
research with the greatest impact throughout the world, leading to results as
soon as possible.
Moving Research from Bench to Bedside
JDRF is a leading catalyst for development science that delivers treatments and
cures to improve the lives of people with diabetes in the near term. Working
toward this goal, JDRF has taken the lead in translating basic research
breakthroughs into cure therapies in such areas as restoring autoimmunity,
preventing and reversing complications, islet replacement, beta cell
regeneration, and achieving metabolic control. The Foundation creates
multidisciplinary programs that bring together diabetes researchers from both
academic institutions and industry to find a cure for diabetes and its
complications.